Visawe:

1,3,5-Triazin-2(1H)-moja, 4-aMino-1-β-D-ribofuranosyl-;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin- 2(1H) -moja
Ladakamycin;Azacitidine(5-Azacitidine);Azacitidine(Vidaza);4-aMino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-1 ,3,5-triazin-2(1H)-moja;Azacitidine (150 mg);4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran -2-yl)-1,3,5-triazin-2;4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-moja
Ladakamycin

TABASAMU za Kisheria:C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N

Msimbo wa HS:29349990

Msongamano:1.4287 (makadirio)

Kuchemka:387.12°C(makadirio makali)

Kielezo cha Refractive:1.6590 (makadirio)

Kiwango cha kuyeyuka:226-232 °C(Desemba)(taa.)

alfa:40o(C=1,H2O22oC)

Hifadhi:2-8°C

PKA:13.46±0.70(Iliyotabiriwa)

Mwonekano:poda ya lyophilized

Misimbo ya Hatari:T

Taarifa za Hatari:45-46-22

Taarifa za Usalama:53-22-36/37/39-45

WGK Ujerumani:3